At Manningham Medical Centre, you can find all the data about Michel Farnier Point Medical. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Michel Farnier | Radcliffe Vascular

    https://www.radcliffevascular.com/authors/michel-farnier
    Dr Farnier is a Doctor of Medicine, a researcher and a teacher. His interests include dyslipidaemia, particularly its genetic aspects. He has conducted extensive research into …

Michel Farnier | AER Journal

    https://www.aerjournal.com/authors/michel-farnier
    Dr Farnier is a Doctor of Medicine, a researcher and a teacher. His interests include dyslipidaemia, particularly its genetic aspects. He has conducted extensive research into …

Michel Farnier | Radcliffe Cardiology

    https://www.radcliffecardiology.com/authors/michel-farnier
    Dr Farnier is a Doctor of Medicine, a researcher and a teacher. His interests include dyslipidaemia, particularly its genetic aspects. He has conducted extensive research …

Future Lipid-Altering Therapeutic Options Targeting …

    https://pubmed.ncbi.nlm.nih.gov/27216845/
    1 Lipid Clinic, Point Medical, 21000, Dijon, France. [email protected]. PMID: 27216845 DOI: 10.1007/s11886-016-0743-8 Abstract Low-density lipoproteins (LDL) play …

Michel FARNIER | Research profile - Page 2

    https://www.researchgate.net/profile/Michel-Farnier/2
    Michel Farnier Background: The majority of ODYSSEY Phase 3 clinical trials of the PCSK9 inhibitor alirocumab (ALI) utilized a dose increase strategy designed to individualize LDL …

PCSK9: From discovery to therapeutic applications

    https://pubmed.ncbi.nlm.nih.gov/24373748/
    The proprotein convertase subtilisin/kexin type 9 (PCSK9) regulates cholesterol metabolism mainly by targeting the low-density lipoprotein receptor (LDLR) for degradation in the …

ESC 2019: Dyslipidaemia Guidelines | Radcliffe Cardiology

    https://www.radcliffecardiology.com/video-index/esc-2019-dyslipidaemia-guidelines
    Dr Michel Farnier (Point Medical Clinic, Dijon, FR) discusses dyslipidaemia guidelines - What are the key updates? Filmed on site at ESC 2019 by Radcliffe Cardiology.

Michel FARNIER | Research profile

    https://www.researchgate.net/profile/Michel-Farnier
    Michel Farnier Eric Bruckert [...] Olivier Ziegler Background and aims Heterozygous familial hypercholesterolemia (HeFH) is increasingly better diagnosed and treatments can …

Log in to Wiley Online Library

    https://onlinelibrary.wiley.com/doi/10.1111/j.1742-1241.2006.01124.x
    Dr Michel Farnier, Point Médical, Rond Point de la Nation, 21000 Dijon, France Tel.: + 33 3 80 70 38 13 Fax: + 33 3 80 70 38 94 Email: [email protected]

Point Medical | OEM Silicone Solutions

    http://pointmedical.com/
    Point Medical engineers and technicians work closely with customers and clinical consultants to provide the best solutions to complex problems and applications. Let us …



Need more information about Michel Farnier Point Medical?

At Manningham Medical Centre, we collected data on more than just Michel Farnier Point Medical. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.